Even though changes in fat-soluble vitamins and in trace element levels have been found after onset of CFTR-modulator therapy there still is a lack of data regarding these changes after initiation of highly-effective CFTR-modulator therapy with ETI in a larger cohort and especially in children with CF. This evidence concerns the gene CFTR and cystic fibrosis.